The global Durvalumab market size was valued at US$ 2.34 billion in 2024 and is projected to reach US$ 4.57 billion by 2030, at a CAGR of 11.8% during the forecast period 2024-2030.
This report provides a deep insight into the global Durvalumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Market Segmentation (by Type)
2.4mL Injection
10mL Injection
Market Segmentation (by Application)
Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other
Get FREE Sample of this Report at :
https://www.24marketresearch.com/download-free-sample/8010045/global-durvalumab-2024-85https://www.24marketresearch.com/download-free-sample/8010045/global-durvalumab-2024-85
Locked
